 Holly McCoppin
Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 2 | 2011 | 850 | 0.400 |
Why?
| | Histiocytoma, Malignant Fibrous | 1 | 2011 | 5 | 0.360 |
Why?
| | Histiocytoma, Benign Fibrous | 1 | 2011 | 7 | 0.360 |
Why?
| | Telangiectasis | 1 | 2011 | 7 | 0.340 |
Why?
| | Skin Diseases, Vascular | 1 | 2011 | 8 | 0.340 |
Why?
| | Fibroma | 1 | 2010 | 20 | 0.320 |
Why?
| | Laser Therapy | 1 | 2011 | 140 | 0.300 |
Why?
| | Leg | 1 | 2011 | 240 | 0.290 |
Why?
| | Kidney Transplantation | 2 | 2011 | 709 | 0.230 |
Why?
| | Heart Transplantation | 1 | 2011 | 674 | 0.220 |
Why?
| | Liver Transplantation | 1 | 2011 | 826 | 0.210 |
Why?
| | Dermatology | 1 | 2019 | 128 | 0.130 |
Why?
| | Drug Prescriptions | 1 | 2019 | 283 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2011 | 1145 | 0.110 |
Why?
| | Lasers, Dye | 1 | 2011 | 2 | 0.090 |
Why?
| | Muir-Torre Syndrome | 1 | 2011 | 1 | 0.090 |
Why?
| | Adenoma, Sweat Gland | 1 | 2011 | 2 | 0.090 |
Why?
| | Lasers, Semiconductor | 1 | 2011 | 11 | 0.090 |
Why?
| | Acute Generalized Exanthematous Pustulosis | 1 | 2011 | 4 | 0.080 |
Why?
| | Anemia, Hemolytic | 1 | 2011 | 16 | 0.080 |
Why?
| | Spider Venoms | 1 | 2011 | 11 | 0.080 |
Why?
| | Lasers, Solid-State | 1 | 2011 | 22 | 0.080 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2011 | 53 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1142 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1360 | 0.080 |
Why?
| | Biopsy, Needle | 1 | 2010 | 184 | 0.080 |
Why?
| | Cyclosporine | 1 | 2011 | 255 | 0.080 |
Why?
| | Shoulder | 1 | 2010 | 105 | 0.080 |
Why?
| | Rare Diseases | 1 | 2010 | 115 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2011 | 8284 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1705 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 834 | 0.060 |
Why?
| | Follow-Up Studies | 1 | 2010 | 5414 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 23 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2011 | 11735 | 0.040 |
Why?
| | Humans | 6 | 2019 | 144667 | 0.030 |
Why?
| | Male | 4 | 2019 | 72431 | 0.020 |
Why?
| | Middle Aged | 2 | 2011 | 35971 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1569 | 0.020 |
Why?
| | Urobilinogen | 1 | 2011 | 1 | 0.020 |
Why?
| | Aged | 1 | 2011 | 25955 | 0.020 |
Why?
| | Coombs Test | 1 | 2011 | 5 | 0.020 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2011 | 27 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 161 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2011 | 269 | 0.020 |
Why?
| | Sirolimus | 1 | 2011 | 280 | 0.020 |
Why?
| | Dopamine | 1 | 2011 | 291 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1044 | 0.020 |
Why?
| | Female | 2 | 2019 | 78304 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2011 | 405 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1652 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2011 | 597 | 0.010 |
Why?
| | Heart Failure | 1 | 2011 | 2324 | 0.010 |
Why?
| | Child | 1 | 2011 | 22600 | 0.010 |
Why?
|
|
McCoppin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|